The Role of Selected Epigenetic Pathways in Cardiovascular Diseases as a Potential Therapeutic Target

被引:4
|
作者
Wolowiec, Anna [1 ]
Wolowiec, Lukasz [2 ]
Grzesk, Grzegorz [2 ]
Jasniak, Albert [2 ]
Osiak, Joanna [2 ]
Husejko, Jakub [2 ]
Kozakiewicz, Mariusz [1 ]
机构
[1] Nicolaus Copernicus Univ, Dept Geriatr, Div Biochem & Biogerontol, Coll Med Bydgoszcz, PL-87100 Torun, Poland
[2] Nicolaus Copernicus Univ, Fac Hlth Sci, Dept Cardiol & Clin Pharmacol, Coll Med Bydgoszcz, PL-87100 Torun, Poland
关键词
epigenetics; cardiovascular diseases; heart failure; ten-eleven translocation enzymes; TET enzymes; FACTOR-KAPPA-B; DNA METHYLATION; HISTONE DEACETYLASES; HEART-FAILURE; INFLAMMATION; INHIBITION; EXPRESSION; GENES; CHROMATIN; MUSCLE;
D O I
10.3390/ijms241813723
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epigenetics is a rapidly developing science that has gained a lot of interest in recent years due to the correlation between characteristic epigenetic marks and cardiovascular diseases (CVDs). Epigenetic modifications contribute to a change in gene expression while maintaining the DNA sequence. The analysis of these modifications provides a thorough insight into the cardiovascular system from its development to its further functioning. Epigenetics is strongly influenced by environmental factors, including known cardiovascular risk factors such as smoking, obesity, and low physical activity. Similarly, conditions affecting the local microenvironment of cells, such as chronic inflammation, worsen the prognosis in cardiovascular diseases and additionally induce further epigenetic modifications leading to the consolidation of unfavorable cardiovascular changes. A deeper understanding of epigenetics may provide an answer to the continuing strong clinical impact of cardiovascular diseases by improving diagnostic capabilities, personalized medical approaches and the development of targeted therapeutic interventions. The aim of the study was to present selected epigenetic pathways, their significance in cardiovascular diseases, and their potential as a therapeutic target in specific medical conditions.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] The role of sphingolipids in selected cardiovascular diseases
    Kurek, Krzysztof
    Piotrowska, Dominika M.
    Wiesiolek-Kurek, Patrycja
    Chabowska, Anna
    Lukaszuk, Bartlomiej
    Zendzian-Piotrowska, Malgorzata
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2013, 67 : 1018 - 1026
  • [32] Senescent Cells: A Therapeutic Target in Cardiovascular Diseases
    Suda, Masayoshi
    Paul, Karl H.
    Minamino, Tohru
    Miller, Jordan D.
    Lerman, Amir
    Ellison-Hughes, Georgina M.
    Tchkonia, Tamar
    Kirkland, James L.
    CELLS, 2023, 12 (09)
  • [33] The therapeutic potential of sphingolipids for cardiovascular diseases
    Bar, Sapir Ya'ar
    Pintel, Noam
    Abd Alghne, Hesen
    Khattib, Hamdan
    Avni, Dorit
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [34] Angiotensinogen as a Therapeutic Target for Cardiovascular and Metabolic Diseases
    Daugherty, Alan
    Sawada, Hisashi
    Sheppard, Mary B.
    Lu, Hong S.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44 (05) : 1021 - 1030
  • [35] AMPK - A NOVEL THERAPEUTIC TARGET IN CARDIOVASCULAR DISEASES
    Heidrich, F.
    Schuenemann, J.
    Mokashi, S. A.
    Schmitto, J. D.
    DRUGS OF THE FUTURE, 2010, 35 (05) : 429 - 435
  • [36] Toll-like Receptors Signaling Pathways as a Potential Therapeutic Target in Cardiovascular Disease
    Parizadeh, Seyed Mostafa
    Ghandehari, Maryam
    Heydari-majd, Motahareh
    Seifi, Sima
    Mardani, Ramin
    Parizadeh, Seyed Mohamadreza
    Ghayour-Mobarhan, Majid
    Ferns, Gordon A.
    Hassanian, Seyed Mahdi
    Avan, Amir
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (17) : 1893 - 1904
  • [37] Is CD47 a potentially promising therapeutic target in cardiovascular diseases? - Role of CD47 in cardiovascular diseases
    Cheng, Quanli
    Gu, Junlian
    Adhikari, Binay Kumar
    Sun, Liguang
    Sund, Jian
    LIFE SCIENCES, 2020, 247
  • [38] The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target
    Yang, Yun
    Ye, Wen-Long
    Zhang, Ruo-Nan
    He, Xiao-Shun
    Wang, Jing-Ru
    Liu, Yu-Xuan
    Wang, Yi
    Yang, Xue-Mei
    Zhang, Yu-Juan
    Gan, Wen-Juan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [39] Mechanistic insights into heat shock protein 27, a potential therapeutic target for cardiovascular diseases
    Zou, Yifei
    Shi, Henghe
    Liu, Ning
    Wang, He
    Song, Xianjing
    Liu, Bin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [40] MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target
    Zhang, Meng-Wan
    Shen, Yun-Jie
    Shi, Jing
    Yu, Jian-Guang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 7